Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion. […]Read More… from Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion.
Mechanism of IGF induced epithelial-to-mesenchymal transition (EMT) in melanoma progression […]Read More… from Mechanism of IGF induced epithelial-to-mesenchymal transition (EMT) in melanoma progression
Prognostic Impact of Immune Checkpoint Inhibitor Expression and Its Association with Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma […]Read More… from Prognostic Impact of Immune Checkpoint Inhibitor Expression and Its Association with Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
Epithelial-to-mesenchymal transition as a robust biomarker and a novel strategy to enhance response to immune checkpoint blockade and targeted therapy in patients with metastatic renal cell carcinoma […]Read More… from Epithelial-to-mesenchymal transition as a robust biomarker and a novel strategy to enhance response to immune checkpoint blockade and targeted therapy in patients with metastatic renal cell carcinoma
Interplay Between Immune Checkpoint Modulators and the Epithelial-to-Mesenchymal Transition Axis in Clear Cell Renal Cell Carcinoma […]Read More… from Interplay Between Immune Checkpoint Modulators and the Epithelial-to-Mesenchymal Transition Axis in Clear Cell Renal Cell Carcinoma
Nanotechnology in the Generation and Analysis of Single Cells […]Read More… from Nanotechnology in the Generation and Analysis of Single Cells
Recent Developments in Single-Cell Transcriptomics […]Read More… from Recent Developments in Single-Cell Transcriptomics
Synthetic Biology in Precision Medicine and Nanotechnology […]Read More… from Synthetic Biology in Precision Medicine and Nanotechnology
Thrombospondin-1 promotes an aggressive phenotype through epithelial-to mesenchymal transition in human melanoma […]Read More… from Thrombospondin-1 promotes an aggressive phenotype through epithelial-to mesenchymal transition in human melanoma
PAPP-A is a marker of aggressive breast cancer and promotes cancer progression in-vitro […]Read More… from PAPP-A is a marker of aggressive breast cancer and promotes cancer progression in-vitro
Immune checkpoint inhibitors and tumor mutation burden as predictive biomarkers in hepatocellular carcinoma […]Read More… from Immune checkpoint inhibitors and tumor mutation burden as predictive biomarkers in hepatocellular carcinoma
Exosome-based liquid biopsy in the management of hepatocellular carcinoma […]Read More… from Exosome-based liquid biopsy in the management of hepatocellular carcinoma
Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma […]Read More… from Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma
Advances in CRISPR/Cas systems-based cell and gene therapy […]Read More… from Advances in CRISPR/Cas systems-based cell and gene therapy
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study […]Read More… from Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study
Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma. […]Read More… from Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma.
Combined inhibition of TGF-β1-induced EMT and PD-L1 silencing re-sensitizes hepatocellular carcinoma to Sorafenib treatment. […]Read More… from Combined inhibition of TGF-β1-induced EMT and PD-L1 silencing re-sensitizes hepatocellular carcinoma to Sorafenib treatment.
CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer […]Read More… from CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer
Determinants of Resistance to VEGF-TKI and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma […]Read More… from Determinants of Resistance to VEGF-TKI and Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma
Patterns of use of adjuvant therapy in patients with stage 1 NSGCT […]Read More… from Patterns of use of adjuvant therapy in patients with stage 1 NSGCT
Effect of pregnant sera and a pregnancy-associated metalloproteinase (PAPP-A) on melanoma in vitro and in vivo: Insights into melanoma progression during pregnancy and potential new therapeutic targets. […]Read More… from Effect of pregnant sera and a pregnancy-associated metalloproteinase (PAPP-A) on melanoma in vitro and in vivo: Insights into melanoma progression during pregnancy and potential new therapeutic targets.
Embryonic chicken transplantation is a promising model for studying the invasive behavior of melanoma cells […]Read More… from Embryonic chicken transplantation is a promising model for studying the invasive behavior of melanoma cells
Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy […]Read More… from Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy
Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells […]Read More… from Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy. […]Read More… from Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy.
Identifying and targeting determinants of melanoma cellular invasion […]Read More… from Identifying and targeting determinants of melanoma cellular invasion
abs# 11 Patterns of Use of Adjuvant Therapy in Patients with Stage 1 Nsgct […]Read More… from abs# 11 Patterns of Use of Adjuvant Therapy in Patients with Stage 1 Nsgct
Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes […]Read More… from Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes
Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer […]Read More… from Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer
Associate Professor Prashanth PrithvirajAssociate Professor Prashanth Prithviraj
Associate Professor Prashanth Prithviraj